Ledger.Open graph →
SEC Form D · filed April 12, 2019

Palvella Therapeutics, Inc

Offering
$4.0M
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WAYNE, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Wesley H. Kaupinen · Wayne, PAExec · DirectorTodd H. Davis · Wayne, PADirectorElaine H. Heron · Wayne, PADirectorTimothy H. Henkel · Wayne, PADirectorMichael H. Christopher · Wayne, PADirectorGeorge H. Jenkins · Wayne, PADirectorEric D. Chin · San Carlos, CADirectorAntonios T. Valamontes · Largo, FLExec · DirectorBrandon Alexander · San Carlos, CADirectorJohn T. Karantonis · Norridge, ILDirectorJames J. Cunnane, Jr · St. Louis, MODirectorTom Broussard · Boston, MADirectorMichael Konnert · VANCOUVER, British Columbia, CanadaExec · DirectorCraig Parry · VANCOUVER, British Columbia, CanadaDirectorCharles Funk · VANCOUVER, British Columbia, CanadaDirectorKimberley Yates · Redwood City, CADirectorAlan Hartman · Redwood City, CADirectorMichael Kaplan · Redwood City, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗